New variants of the virus are becoming increasingly transmissible, raising concerns about their impact in the U.S. Due to limited genomic surveillance, understanding the prevalence of these variants remains a challenge. Continuous sequencing is crucial to monitor potential mutations that could evade vaccine-induced immunity as vaccination rates increase.
